(Q54466640)

30 May 2018

title

Interactions between calcium antagonists, calcium fluxes and anthracycline transport (English)

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

4 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

4 August 2023

author name string

D. Kessel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6097354

4 August 2023

C. Wilberding

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6097354

4 August 2023

language of work or name

English

0 references

publication date

1 November 1984

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0304383584800312?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

https://api.elsevier.com/content/article/PII:S0304383584800312?httpAccept=text/plain

4 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

4 August 2023

1 reference

30 May 2018

volume

25

1 reference

30 May 2018

issue

1

1 reference

30 May 2018

page(s)

97-101

1 reference

30 May 2018

Biochemical Parameters of Resistance of an Adriamycin-Resistant Subline of P388 Leukemia to Emetine, an Inhibitor of Protein Synthesis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

m-AMSA as a probe for transport phenomena associated with anthracycline resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Mode of action of calcium antagonists which alter anthracycline resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Verapamil Restoration of Daunorubicin Responsiveness in Daunorubicin-resistant Ehrlich Ascites Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2884%2980031-2

7 January 2021

Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia

3

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

Uptake and retention of daunomycin by mouse leukemic cells as factors in drug response

4 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells

4 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

4 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0304-3835(84)80031-2

4 August 2023

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018